However, expanding this to two-dimensional systems presented new challenges, including the risk of disruptions in the liquid-crystal patterns that would affect light behavior. To overcome this ...

A third poster is a case study of a patient with PAH participating in the open-label extension study (INSPIRE).

A third poster is a case study of a patient with PAH participating in the open-label extension study (INSPIRE). Poster Discussion Session: Poster Board #1404 Date and time: Tuesday, May 20 ...

A third poster is a case study of a patient with PAH participating in the open-label extension study (INSPIRE). YUTREPIA is an investigational, inhaled dry-powder formulation of treprostinil delivered ...